2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Monocytic Leukemia: new trials by email Literature Review of Monocytic Leukemia trials Research Report on Monocytic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation Enasidenib mesylat dose escalation - Leukemia, Leukemia, Myeloid | Phase 1 / Phase 2 | Completed | Tian Yi Zhang | 17 | 2022-01-12 | 2026-09-03 |
| Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients Intravenous (IV) and oral Vitamin C - Lymphoid Leukemia, Myeloid Leukemia | Phase 2 | Completed | Virginia Commonwealth University | 61 | 2018-10-01 | 2023-11-07 |
Leukemia, Monocytic, Acute (2) · Leukemia, Myeloid (2) · Anemia, Refractory, with Excess of Blasts (1) · Graft vs Host Disease (1) · Leukemia (1) · Leukemia, Lymphoid (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia, Myeloid, Acute (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Anemia (1) · Anemia, Refractory (1) · Bone Marrow Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Myelodysplastic Syndromes (1)
Ascorbic Acid (1) · enasidenib (1)
Tian Yi Zhang (1) · Virginia Commonwealth University (1)
United States (2)
Tian Yi Zhang, MD (1) · William B Clark, MD (1)